Liquid Biopsy: circulating plasma free DNA (cfDNA) as a novel prognostic and diagnostic marker in disease states
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Liquid Biopsy: circulating plasma free DNA (cfDNA) as a novel prognostic and diagnostic marker in disease states ; volume:55 ; number:s2 ; year:2017 ; pages:s1142-s1144 ; extent:3
Clinical chemistry and laboratory medicine ; 55, Heft s2 (2017), s1142-s1144 (gesamt 3)
- DOI
-
10.1515/cclm-2017-7007
- URN
-
urn:nbn:de:101:1-2022061715554889274572
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Ähnliche Objekte (12)
Liquid biopsy and circulating free plasma DNA
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA
Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA
Über die Proteinbindung frei zirkulierender DNA (cfDNA)
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
Liquid biopsy and circulating free plasma DNA
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA
Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA
Über die Proteinbindung frei zirkulierender DNA (cfDNA)
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
Liquid biopsy and circulating free plasma DNA
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA
Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA
Über die Proteinbindung frei zirkulierender DNA (cfDNA)
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer